Search Results - "Vécsei, Laszló"

Refine Results
  1. 1

    Therapeutic Approaches for Peripheral and Central Neuropathic Pain by Vécsei, László, Nyári, Aliz, Tajti, János, Szok, Délia

    Published in Behavioural neurology (2019)
    “…Neuropathic pain is a chronic secondary pain condition, which is a consequence of peripheral or central nervous (somatosensory) system lesions or diseases. It…”
    Get full text
    Journal Article
  2. 2

    Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System by Tanaka, Masaru, Szabó, Ágnes, Spekker, Eleonóra, Polyák, Helga, Tóth, Fanni, Vécsei, László

    Published in Cells (Basel, Switzerland) (21-08-2022)
    “…Nearly half a century has passed since the discovery of cytoplasmic inheritance of human chloramphenicol resistance. The inheritance was then revealed to take…”
    Get full text
    Journal Article
  3. 3

    Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain by Tajti, János, Szok, Délia, Csáti, Anett, Szabó, Ágnes, Tanaka, Masaru, Vécsei, László

    “…Migraine and neuropathic pain (NP) are both painful, disabling, chronic conditions which exhibit some symptom similarities and are thus considered to share a…”
    Get full text
    Journal Article
  4. 4

    Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway by Tanaka, Masaru, Tóth, Fanni, Polyák, Helga, Szabó, Ágnes, Mándi, Yvette, Vécsei, László

    Published in Biomedicines (25-06-2021)
    “…The tryptophan (TRP)-kynurenine (KYN) metabolic pathway is a main player of TRP metabolism through which more than 95% of TRP is catabolized. The pathway is…”
    Get full text
    Journal Article
  5. 5

    Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson’s disease by Maszlag-Török, Rita, Boros, Fanni A., Vécsei, László, Klivényi, Péter

    Published in Scientific reports (21-05-2021)
    “…Parkinson’s disease (PD) is a neurodegenerative disease caused by complex interaction between genetic and environmental factors. There is a growing body of…”
    Get full text
    Journal Article
  6. 6

    Changing the face of kynurenines and neurotoxicity: therapeutic considerations by Bohár, Zsuzsanna, Toldi, József, Fülöp, Ferenc, Vécsei, László

    “…Kynurenines are the products of tryptophan metabolism. Among them, kynurenine and kynurenic acid are generally thought to have neuroprotective properties,…”
    Get full text
    Journal Article
  7. 7

    The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain by Martos, Diána, Lőrinczi, Bálint, Szatmári, István, Vécsei, László, Tanaka, Masaru

    “…The central nervous system (CNS) is the final frontier in drug delivery because of the blood-brain barrier (BBB), which poses significant barriers to the…”
    Get full text
    Journal Article
  8. 8

    Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease by Szökő, Éva, Tábi, Tamás, Riederer, Peter, Vécsei, László, Magyar, Kálmán

    Published in Journal of Neural Transmission (01-11-2018)
    “…The era of MAO-B inhibitors dates back more than 50 years. It began with Kálmán Magyar’s outstanding discovery of the selective inhibitor, selegiline. This…”
    Get full text
    Journal Article
  9. 9

    Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis by Rajda, Cecilia, Pukoli, Dániel, Bende, Zsuzsanna, Majláth, Zsófia, Vécsei, László

    “…Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). There is increasing evidence that MS is not only characterized…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway by Tanaka, Masaru, Török, Nóra, Tóth, Fanni, Szabó, Ágnes, Vécsei, László

    Published in Biomedicines (26-07-2021)
    “…Chronic pain is an unpleasant sensory and emotional experience that persists or recurs more than three months and may extend beyond the expected time of…”
    Get full text
    Journal Article
  12. 12

    Proteomics in Multiple Sclerosis: The Perspective of the Clinician by Sandi, Dániel, Kokas, Zsófia, Biernacki, Tamás, Bencsik, Krisztina, Klivényi, Péter, Vécsei, László

    “…Multiple sclerosis (MS) is the inflammatory demyelinating and neurodegenerative disease of the central nervous system (CNS) that affects approximately 2.8…”
    Get full text
    Journal Article
  13. 13

    Neuroprotection in Parkinson’s disease: facts and hopes by Salamon, András, Zádori, Dénes, Szpisjak, László, Klivényi, Péter, Vécsei, László

    Published in Journal of Neural Transmission (01-05-2020)
    “…Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. Behind the symptoms there is a complex pathological mechanism which…”
    Get full text
    Journal Article
  14. 14

    Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome by Péter, Mária, Török, Wanda, Petrovics-Balog, Anna, Vígh, László, Vécsei, László, Balogh, Gábor

    Published in Scientific reports (27-10-2020)
    “…Multiple sclerosis (MS) and Guillain – Barré syndrome (GBS) are demyelinating disorders affecting the central nervous system and peripheral nervous system…”
    Get full text
    Journal Article
  15. 15

    Non-invasive Brain Stimulation in Alzheimer's Disease and Mild Cognitive Impairment-A State-of-the-Art Review on Methodological Characteristics and Stimulation Parameters by Holczer, Adrienn, Németh, Viola Luca, Vékony, Teodóra, Vécsei, László, Klivényi, Péter, Must, Anita

    Published in Frontiers in human neuroscience (25-05-2020)
    “…Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) have been proposed as a new therapeutic way to enhance the cognition…”
    Get full text
    Journal Article
  16. 16

    Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System by Rajda, Cecilia, Majláth, Zsófia, Pukoli, Dániel, Vécsei, László

    “…Multiple sclerosis is an inflammatory disease of the central nervous system, in which axonal transection takes place in parallel with acute inflammation to…”
    Get full text
    Journal Article
  17. 17

    Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis by Rajda, Cecilia, Galla, Zsolt, Polyák, Helga, Maróti, Zoltán, Babarczy, Kristóf, Pukoli, Dániel, Vécsei, László

    “…Neurofilament light (NFL) has proved to be a good prognostic factor in multiple sclerosis (MS), as its level is proportionally elevated with extended…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression by Zádor, Ferenc, Joca, Sâmia, Nagy-Grócz, Gábor, Dvorácskó, Szabolcs, Szűcs, Edina, Tömböly, Csaba, Benyhe, Sándor, Vécsei, László

    “…Substance use/abuse is one of the main causes of depressive symptoms. Cannabis and synthetic cannabinoids in particular gained significant popularity in the…”
    Get full text
    Journal Article
  20. 20